Sponsors

We would like to thank our sponsors for their support

The Simons Foundation Fund was set up on 18 September 1975 by the Dutch Anthropogenetic Society (NAV) with a legacy from J.E. Simons. The foundation's aim is to encourage the study of human genetics and to promote and disseminate knowledge on hereditary diseases by sponsoring conference visits and providing financial support to young researchers for scientific visits.

Agilent Genomics Applications and Solutions

Agilent is committed to helping scientists bring great science to life. As they pursue, everyday advances and life-changing discoveries, we provide trusted

answers to scientists’ and clinicians’ most critical questions and challenges.

At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture and industrial chemicals, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts. Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing and therapeutics discovery, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com.

Centogene is a leading company in the field of genetic diagnostics and precision medicine, dedicated to transforming clinical, genetic, and biochemical data into medical solutions for patients. Based in Rostock, Germany, the company operates globally.

Founded in 2006 with the mission of revolutionizing the diagnosis of rare diseases, Centogene proudly celebrates its 20th anniversary this year, marking two decades of scientific innovation and commitment to patients worldwide. Since its founding, the company has scaled its capabilities to diagnose more than 2,500 rare diseases in over 100 countries, building one of the largest genetic databases in the world (1,000,000 individuals) while developing cutting-edge technology for the interpretation of genetic data. With over 350 scientific publications, Centogene is a key partner for physicians in rapid and accurate genetic diagnosis, and for pharmaceutical companies focused on developing treatments for orphan diseases.

Novogene is a global leader in multiomics services, offering comprehensive solutions in genomics, transcriptomics, epigenomics, proteomics, metabolomics, and bioinformatics. With one of the world’s largest sequencing capacities and labs across continents, Novogene enables coordinated multiomics workflows through a single provider. Backed by 70+ patents and 30,000+ publications in leading journals, and using platforms like Illumina, PacBio, Oxford Nanopore, 10X Genomics, and Olink®, Novogene supports research across academic, clinical, and pharmaceutical fields worldwide. 

Devyser is a Swedish molecular diagnostics company pioneering fast, accurate, and easy-to-use genetic testing solutions for clinical laboratories worldwide; its range of CE-IVD kits supports advanced DNA testing in areas such as hereditary diseases, oncology, transplant monitoring and reproductive health. With a mission to simplify lab workflows and accelerate personalized healthcare, Devyser’s innovative assays and software help deliver reliable diagnoses and guide targeted treatment decisions.

In Benelux, devyser is representing 'Nonacus  Ltd, a UK-based genomics company and innovator in molecular diagnostics, specializing in cell-free DNA (cfDNA), targeted sequencing, and next-generation sequencing (NGS) applications for oncology and prenatal diagnostics. Their solutions are designed for clinical and research laboratories seeking high performance, exceptional sensitivity, and enhanced workflow efficiency.